SCHEMBL3767511

SCHEMBL3767511

Fc1ccc(F)c(/C(=C/c2ccc(Cl)cc2)CCl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
MDM2 Q00987 9/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
MAOB P27338 1/20 0.40
MAPT P10636 2/20 0.37
NPC1 O15118 1/20 0.37
PTGES2 Q9H7Z7 2/20 0.37
P2RX7 Q99572 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
KCNA3 P22001 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3767517 1.00 ALDH1A1 (0.41) ALDH1A1HTTMDM2CES2CES1
SCHEMBL3124324 0.89 MAOB (0.43) ALDH1A1HTTMDM2CES2CES1
SCHEMBL3124317 0.89 MAOB (0.43) ALDH1A1HTTMDM2CES2CES1
SCHEMBL3769829 0.84 MDM2 (0.40) ALDH1A1MDM2CES2CES1PTGES2
SCHEMBL3769833 0.84 MDM2 (0.40) ALDH1A1MDM2CES2CES1PTGES2
SCHEMBL3665474 0.83 PTGS1 (0.39) ALDH1A1HTTMAOBCYP11B1CYP11B2
SCHEMBL3777736 0.83 PTGS1 (0.39) ALDH1A1HTTMAOBCYP11B1CYP11B2
SCHEMBL2799013 0.81 MAPT (0.41) ALDH1A1HTTCES2CES1MAPT
SCHEMBL2799017 0.81 MAPT (0.41) ALDH1A1HTTCES2CES1MAPT
SCHEMBL3660731 0.79 HPGD (0.41) ALDH1A1HTTMAOBMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same BASF SE (DE) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same XDH, NOX5, TET1 ALDH1A1 20/4885HTT 3139/4885MDM2 3459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.